Saturday, June 11, 2022
11:00 AM – 12:30 PM EDT
1.5 CME Credits
Click here to register for the webinar.
Moderators:
Viviane Nasr, MD, MPH
DISCLOSURE: Nothing to disclose.
David Faraoni, MD, PhD
DISCLOSURE: Nothing to disclose.
Presentations/Speakers/Disclosures:
Current and future therapies: the basic science perspective
– Neil Goldenberg, MD, PhD, Hospital for Sick Children
DISCLOSURE: Nothing to disclose.
Learning Objectives:
- To review current models of pulmonary arterial hypertension pathogenesis
- To review new pathways of interest in PAH at the cellular/vascular level
- To discuss translational approaches to PAH management currently under investigation
The role of echocardiography, MRI, cardiac catheterization, and lung biopsy in the diagnosis of pulmonary hypertension
– Mary Mullen, MD, PhD; Boston Children’s Hospital
DISCLOSURE: Pediatric Pulmonary Hypertension Scientific Advisory Board, Altavant Science
Learning Objectives:
- Describe a systematic approach to the diagnosis and characterization of pulmonary hypertension in children
- Understand the role of multiple testing modalities to evaluate the child with pulmonary hypertension
- Formulate an assessment of the child with pulmonary hypertension based on classification, clinical status and disease severity
Lung transplantation for pulmonary hypertension and strategies to bridge to transplant
– Adam Stephens, MD, Texas Children’s Hospital
DISCLOSURE: Nothing to disclose.
Learning Objectives:
- Understand the institutional experience with the pediatric pulmonary hypertension patient subset who has progressed to transplant
- Have a broad understanding of the operative techniques of pediatric lung transplant and the various iterations of the procedure as it has been performed at this institution
- Better understand methods that have been used to bridge the pediatric pulmonary hypertension patient to lung transplant and in particular, a unique approach used at this institution
Anesthetic management of the child with pulmonary hypertension for diagnostic imaging and surgery
– Jochen Steppan, MD Johns Hopkins
DISCLOSURE: Nothing to disclose.
Learning Objectives:
- To describe the impact of pulmonary hypertension on perioperative outcomes
- Outline a perioperative management program for pediatric patients with pulmonary hypertension presenting for non-cardiac surgery
- Formulate a perioperative plan for children with pulmonary hypertension that is tailored to the underlying physiology
The Society for Pediatric Anesthesia is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CCAS is a Section of the Society for Pediatric Anesthesia.The Society for Pediatric Anesthesia designates this Other (Live and Enduring Material) activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Education Mission Statement
The CCAS Webinar Series will focus on topics of interest to those who provide anesthesia, sedation, pain management, and critical care services to infants and children with heart disease, and adults with congenital heart disease. The overall goals for attendees of the program are to reinforce and enhance their existing fund of knowledge, while introducing them to new and state-of-the-art techniques and information that affect their practice and improve the perioperative care of patients with heart disease.
